Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 30;25(1):515.
doi: 10.3390/ijms25010515.

Anticytokine Autoantibodies in Infectious Diseases: A Practical Overview

Affiliations
Review

Anticytokine Autoantibodies in Infectious Diseases: A Practical Overview

Rob J W Arts et al. Int J Mol Sci. .

Abstract

Anticytokine autoantibodies (ACAAs) are a fascinating group of antibodies that have gained more and more attention in the field of autoimmunity and secondary immunodeficiencies over the years. Some of these antibodies are characterized by their ability to target and neutralize specific cytokines. ACAAs can play a role in the susceptibility to several infectious diseases, and their infectious manifestations depending on which specific immunological pathway is affected. In this review, we will give an outline per infection in which ACAAs might play a role and whether additional immunomodulatory treatment next to antimicrobial treatment can be considered. Finally, we describe the areas for future research on ACAAs.

Keywords: anti-GM-CSF; anti-interferon; anti-interleukin; cryptococcus; cytokine; non-tuberculous mycobacteria; secondary immunodeficiency.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Overview of most important ACAAs and their suggested mode of action. Central to the process of auto-antibody production are B lymphocytes and plasma cells, which can be targeted with host-directed therapies, such as rituximab (anti-CD20). (A) The cytokines IL-17 and IL-22 are essential in the interaction between epithelial barrier and Candida. IL-17 induces production of antimicrobial peptides and IL-22 enforces epithelial cell proliferation and repair, both through the IL-17-receptor and IL-22-receptor present in epithelial cells. This process is disrupted by anti-IL-17 and anti-IL-22 auto-antibodies. (B) IFNγ produced by Th1-cells is an essential activator of macrophages. It improves killing of intracellular pathogens, such as NTMs and several fungi, and induces IL-12 production, which in turn stimulates IFNγ production by Th1-cells. Anti-IFNγ auto-antibodies disrupt this proinflammatory loop. (C) GM-CSF is essential in the activation of, among others, alveolar macrophages, and the induction of production of reactive oxygen species. Anti-GM-CSF auto-antibodies therefore increase the risk for specific pulmonary infections with Nocardia and cryptococcal species and apart from local infection also increase the risk for disseminated disease such as Nocardia brain abscesses and cryptococcal meningitis. APECED, Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy; GM-CSF, Granulocyte-macrophage colony-stimulating factor; IFN, Interferon; IL, Interleukin; Mφ, macrophage; NTM, Non-tuberculous mycobacteria; Th, T-helper cell.

References

    1. Meager A., Vincent A., Newsom-Davis J., Willcox N. Spontaneous neutralising antibodies to interferon-α and interleukin-12 in thymoma-associated autoimmune disease. Lancet. 1997;350:1596–1597. doi: 10.1016/S0140-6736(05)64012-3. - DOI - PubMed
    1. Cheng A., Holland S.M. Anti-cytokine autoantibodies: Mechanistic insights and disease associations. Nat. Rev. Immunol. 2023 doi: 10.1038/s41577-023-00933-2. - DOI - PubMed
    1. Merkel P.A., Lebo T., Knight V. Functional Analysis of Anti-cytokine Autoantibodies Using Flow Cytometry. Front. Immunol. 2019;10:1517. doi: 10.3389/fimmu.2019.01517. - DOI - PMC - PubMed
    1. von Stemann J.H., Rigas A.S., Thørner L.W., Rasmussen D.G.K., Pedersen O.B., Rostgaard K., Erikstrup C., Ullum H., Hansen M.B. Prevalence and correlation of cytokine-specific autoantibodies with epidemiological factors and C-reactive protein in 8,972 healthy individuals: Results from the Danish Blood Donor Study. PLoS ONE. 2017;12:e0179981. doi: 10.1371/journal.pone.0179981. - DOI - PMC - PubMed
    1. Uchida K., Nakata K., Suzuki T., Luisetti M., Watanabe M., Koch D.E., Stevens C.A., Beck D.C., Denson L.A., Carey B.C., et al. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood. 2009;113:2547–2556. doi: 10.1182/blood-2008-05-155689. - DOI - PMC - PubMed